Urinary Retention: Clinical Trials

11 trials for Urinary Retention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 11 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 6, Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 23Completed 2, Unknown 1

Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Controlled Trial of Different Antibiotic Duration Prior to Prostate Enucleation Surgery
antibiotic prophylaxis - BPH With Urinary Obstruction, Antibiotic Prophylaxis
Phase 3Not yet recruitingOhio State University2502026-01-012025-10-06
Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection
pr Sandoz Tamsulosin, Glucose - Urinary Retention, Colorectal Surgery
Phase 3RecruitingCHU de Quebec-Universite Laval2202023-11-102026-09-10
Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery
Placebo oral capsule, Tamsulosin - Urinary Retention, Lower Urinary Tract Symptoms
Phase 2 / Phase 3CompletedUniversity Hospitals Cleveland Medical Center1322018-08-012021-11-08
The Effect of Catheter Valve Vs. Standard Catheter Removal in Outpatients
Use of catheter valve before 'trial removal of catheter', Trial removal of catheter in patients with urinary retention - Urinary Retention
Phase 2 / Phase 3UnknownMedway NHS Foundation Trust1002016-03-012016-03-28
Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention
Active Voiding Trial, Passive Voiding Trial - Urinary Retention, Urinary Tract Infections
Phase 3CompletedUniversity of Virginia2742015-10-012016-09-01
Prevention of Post-operative Urinary Retention
Tamsulosin, Placebo - Urinary Retention, Urinary Tract Infections
Phase 3CompletedUniversity of Wisconsin, Madison1582015-08-012019-09-25
Tamsulosin for Urinary Retention in Hospitalized Older Women
Tamsulosin (0.4 mg/j), Placebo - Urinary Retention
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris342013-01-012014-10-02
Botulinum Toxin A Injections in Patients With Fowler's Syndrome
onabotulinumtoxinA - Urinary Retention, Fowler's Syndrome
Phase 2 / Phase 3CompletedUniversity College, London102009-11-012015-04-29
Prevention of Acute Voiding Difficulty After Radical Proctectomy
Tamsulosin - Rectal Cancer, Urinary Retention
Phase 3CompletedSeoul National University Hospital1002007-05-012011-07-20
Alfuzosin Versus Placebo in Acute Urinary Retention
Alfuzosin - Urinary Retention
Phase 3TerminatedSanofi1602004-05-012007-08-20
Clinical Trial in Males With BPH (Enlarged Prostate)
Alfuzosin (SL770499) - Urinary Retention, Prostatic Hyperplasia
Phase 3CompletedSanofi15222001-05-012008-06-09

Narrower conditions

Prostatic Hyperplasia (2)  ·  Urinary Tract Infections (2)  ·  Catheter-Related Infections (1)  ·  Fowler Christmas Chapple syndrome (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Pelvic Organ Prolapse (1)  ·  Postoperative Complications (1)  ·  Rectal Neoplasms (1)  ·  Urinary Incontinence, Stress (1)

Broader conditions

Female Urogenital Diseases (11)  ·  Female Urogenital Diseases and Pregnancy Complications (11)  ·  Male Urogenital Diseases (11)  ·  Urination Disorders (11)  ·  Urogenital Diseases (11)  ·  Urologic Diseases (11)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Infections (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Prostatic Diseases (2)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)

Interventions

Tamsulosin (5)  ·  alfuzosin (2)  ·  Antibiotic Prophylaxis (1)  ·  Botulinum Toxins, Type A (1)  ·  Glucose (1)

Sponsors

Sanofi (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  CHU de Quebec-Universite Laval (1)  ·  Medway NHS Foundation Trust (1)  ·  Ohio State University (1)  ·  Seoul National University Hospital (1)  ·  University College, London (1)  ·  University Hospitals Cleveland Medical Center (1)  ·  University of Virginia (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (3)  ·  Canada (2)  ·  Denmark (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Hungary (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Poland (1)  ·  Portugal (1)  ·  Romania (1)

Top investigators

Eric Bouvard, MD (1)  ·  Evie H Carchman, MD (1)  ·  Graham Chapman (1)  ·  Henning Andersen, MD (1)  ·  Shikohe Masood, MD (1)  ·  Sung-Bum Kang, M.D., Ph.D (1)  ·  Tracey L Krupski, MD, MPH (1)

Results publications

PMID 11743295, PMID 15291863, PMID 16536764, PMID 31732771, PMID 33894146, PMID 34184246